Lung Cancer clinical trials
Showing 101–150 of 230 active trials. Describe your situation to see which ones you may be eligible for.
- Molecular and Genetic Analysis of Lung Cancer
- PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
- Specimen Banking From Patients With Lung Cancer
- Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
- Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
- A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
- Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
- Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
- Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
- Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
- Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
- The Intersection of Oncology Care and Worker Well-Being
- 4D-MRI for Precision Medicine
- Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome
- Thoracic Specimen Registry
- DNA Analysis of Blood and Tissue from Patients with Lung Cancer
- Lung Cancer Biomarkers and Screening
- Detection of Genetic Markers of Lung Cancer
- A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
- Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
- Evaluation for NCI Surgery Branch Clinical Research Protocols
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
- Sample Collection for Ongoing Research and Product Evaluation Study
- EXoPERT EMERALD Clinical Study
- End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
- Cough Capture as a Portal Into the Lung
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
- UNC Pleural Fluid Registry
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Integrated Cancer Repository for Cancer Research
- RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- Collection of Blood From Patients With Cancer
- Social Optimization Study
- New York Better Breathing Study
- Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
- Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer
- ACT Lung Health Intervention: Phase Two
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.